繁體中文

研究發表

2024年度研究發表

 

作者(順位) 論文題目 發表期刊
李宛珊(1)
田宇峯(5)
吳麗卿(8)
REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT Histol Histopathol. 2024 Jan;39(1):91-104.
 田宇峯(6) Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy Aging (Albany NY). 2024 May 3;16(9):7889-7901.
李健逢(9) Advantages of retrograde intrarenal incision versus laparoscopic surgery in management of pararenal cysts: a single-center experience Int Urol Nephrol. 2024 Apr;56(4):1307-1313.
李宛珊(6)
李健逢(7)
Clinicopathologic Features and Cytologic Correlation of ALK-Rearranged Papillary Thyroid Carcinoma: A Series of Eight Cases Endocr Pathol. 2024 Apr 20. doi: 10.1007/s12022-024-09808-1.
李健逢(6) Retroperitoneal laparoscopic adrenalectomy for large adrenal tumors-analysis of tumor size and adverse events: a retrospective single-center study Front Surg. 2024 Jan 5:10:1284093.

 

2023年度研究發表

 

作者(順位) 論文題目 發表期刊
 田宇峯(7)
李健逢(13)
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma Oncol Lett. 2023 Oct 30;26(6):533.
 田宇峯(6)
李健逢(10)
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma Eur J Med Res. 2023 Dec 15;28(1):593.
田宇峯(6)
李健逢(10)
Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma Front Biosci (Landmark Ed). 2023 Apr 19;28(4):75.
田宇峯(8) NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis Pathol Res Pract. 2023 Jan:241:154238.
田宇峯(7)
李健逢(13)
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma Sci Rep. 2023 Oct 14;13(1):17444.
田宇峯(3) Incidentally portal vein penetration during cannulation in endoscopic retrograde cholangiopancreatography: a case report J Surg Case Rep. 2023 Jun 5;2023(6):rjad298.
田宇峯(6) Punicalagin is cytotoxic to human colon cancer cells by modulating cell proliferation, apoptosis, and invasion Hum Exp Toxicol. 2023 Jan-Dec:42:9603271231213979.
田宇峯(5) Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarke Diagnostics (Basel). 2023 Jul 6;13(13):2296.
李健逢(5) Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer Int J Biol Macromol. 2023 Aug 1:245:125510.
李宛珊(9)
李健逢(C)
A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases Mod Pathol. 2023 Sep;36(9):100242.
李健逢(2) Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab Front Immunol. 2023 Mar 27:14:1131448.
李健逢(1) PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry Int J Biol Sci. 2023 Jul 31;19(12):3920-3936.
李健逢(9) Deep-learning based breast cancer detection for cross-staining histopathology images Heliyon. 2023 Jan 21;9(2):e13171.
李健逢(4) Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis Front Biosci (Landmark Ed). 2023 Sep 24;28(9):217.
 李健逢(4) Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs Sci Rep. 2023 Mar 9;13(1):3943.
李宛珊(8)
 李健逢(C) 
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder World J Surg Oncol. 2023 Feb 25;21(1):62.
李健逢(5)  Early Postoperative Outcomes of Retroperitoneal Partial Nephrectomy of Anterior and Posterior Renal Tumors: A 5-Year Experience in A Single Center J Endourol. 2023 May;37(5):557-563.
 李健逢(10) The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma Cell Oncol (Dordr). 2023 Aug;46(4):933-951.
李宛珊(17)  Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion Mod Pathol. 2023 Jul;36(7):100161.

 

2022年度研究發表

  

作者(順位) 論文題目 發表期刊
田宇峯(2) GRK3 AS A PROGNOSIS BIOMARKER IN GASTRIC CANCER

J.Cancer. 2022 Jan 31;13(4):1299-1306.

田宇峯(6) SHORT- AND LONG-TERM RECURRENCE OF EARLY-STAGE INVASIVE DUCTAL CARCINOMA IN MIDDLE-AGED AND OLD WOMEN WITH DIFFERENT TREATMENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY Sci Rep: 2022 Mar 15;12(1):4422
田宇峯(4) Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice. Int J Mol Sci: 2022 Nov 17;23(22):14226.
田宇峯(4) Impact of Tumor Location on Survival in Patients With Colorectal Cancer: A Retrospective Cohort Study Based on Taiwan's Cancer Registry Database Clin Med Insights Oncol: 2022 Jul 9;16:117955492211.
田宇峯(5) Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity. Clin Sci (Lond): 2022 Jan 14;136(1):121-137
李健逢(4) Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques. Life (Basel). 2022 Nov 9;12(11):1839. doi: 10.3390/life12111839.
田宇峯(5)
吳麗卿(9)
李健逢(11)
賴弘岳(C)
High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Pathol Res Pract. 2022 Nov;239:154158
田宇峯(2)
李健逢(11) 
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Onco Targets Ther. 2022 Oct 11;15:1171-1181.
李宛珊(8)
李健逢(C) 
High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma. Oncology. 2022;100(9):485-497.
賴弘岳(2)
李宛珊(8)
李健逢(C) 
Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma. Onco Targets Ther. 2022 Jun 30;15:727-740.
李健逢(C)  Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB. Int J Mol Sci. 2022 May 3;23(9):5097.
 李健逢(2) Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers (Basel). 2022 Mar 31;14(7):1787.
賴弘岳(1)
吳麗卿(5)
李健逢(C)
High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis. Front Oncol. 2022 Mar 16;12:834249.
李健逢(C) Editorial: Molecular Mechanisms of Multiple Myeloma Front Oncol. 2022 Mar 16;12:834249.
 李健逢(C) Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression. Cells. 2022 Feb 11;11(4):638.
李健逢(10)  Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Mod Pathol. 2022 Jul;35(7):911-921
 李健逢(3) Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clin Transl Med. 2022 Jan;12(1):e724.
賴弘岳(1)
吳麗卿(2)
龔柏勳(3)
李健逢(C)
High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan. Front Oncol. 2022 Jan 6;11:828314.
李健逢(10) Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions. Am J Surg Pathol. 2022 Jul 1;46(7):942-955.
李健逢(5) Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions. Pathol Res Pract. 2022 Jan;229:153700.
賴弘岳(3) Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma. Clin Med Insights Oncol. 2022 Jul 22;16:11795549221113244.
李健逢(C) The biological impacts of CEBPD on urothelial carcinoma development and progression. Front Oncol. 2023 Jan 27:13:1123776.
李健逢(2,C) Autocrine gremlin 1, DAN family BMP antagonist in urothelial carcinoma. Cellular Oncology
李宛珊(1) High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221141795
李宛珊(3) Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Onco Targets Ther. 2022 Oct 11;15:1171-1181.
田宇峯(5)
李宛珊(7)
Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cance Pathol Oncol Res. 2022 Oct 6;28:1610537
李宛珊(7) High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Pathol Res Pract. 2022 Nov;239:154158
龔柏勳(1)
吳麗卿(5)
李健逢(9)
Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia Pathogens. 2022 May 16;11(5):586.
廖乃鼎(1) 以3D列印嬰兒足後跟模型於醫檢人員採血OSCE應用成效探討 台灣擬真醫學教育期刊/2022/第八卷第一期/15
吳麗卿(5) Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study Nutrients: 2022 Mar 6;14(5):1108.
 吳麗卿(5) Suboptimal Plasma Vitamin C Is Associated with Lower Bone Mineral Density in Young and Early Middle-Aged Men: A Retrospective Cross-Sectional Study Nutrients:2022 Aug 29;14(17):3556

 

 

2021年度研究發表

作者(順位) 論文題目 發表期刊
Lai HY(3), Wu LC(5), Li CF(Co).
Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma.
Front Oncol. 2021 Sep 13;11:749142.
Tsai HH(5), Lai HY(Co)
High SPIN4 Expression Is Linked to Advanced Nodal Status and Inferior Prognosis in Nasopharyngeal Carcinoma Patients.
Life (Basel). 2021 Sep 1;11(9):912.
Li WS(6), Tsai HH(7), Li CF(8), Lai HY(Co).
Upregulated MUC2 Is an Unfavorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative CCRT.
J Clin Med. 2021 Jul 7;10(14):3030.
Li WS(6), Tsai HH(7), Li CF(8), Lai HY(Co).
CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT.
Life (Basel). 2021 Jul 2;11(7):646.
Li WS(6), Tsai HH(7), Li CF(8), Lai HY(Co)
High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
Curr Oncol. 2021 Jun 25;28(4):2373-2384.
Li WS(7), Tsai HH(8), Li CF(9), Lai HY(Co) 
High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.
Int J Clin Oncol. 2021 May 27.
Lai HY(1), Tsai HH(2), Li CF(9). 
Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation.
Front Cell Dev Biol. 2021 Jan 21;8:596655.